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ABSTRACT 
 
Aims: More than 70 percent of the children diagnosed with cancer in Egypt die 
every year. In Sweden the corresponding figure is close to 20 percent. The aims 
of this study was to investigate psycho-oncological predictors of mortality, 
parental perception of the care their child received as well as of the health care 
professionals, in order to improve care of children with cancer. The main 
hypothesis was that parental degree of trust affects a child’s adherence to 
treatment, dose intensity and therefore survival. 
 
Methods: During an 18-month preparatory phase, we carried out in-depth 
interviews, participant observations at the hospital, construction of two study-
specific questionnaires, face-to-face validation of the questionnaires, and 
thereafter, a pilot study testing the logistics. Following that, the main data 
collection was carried out during the recruitment period of February to 
September in 2008. The eligible study population was parents of children newly 
diagnosed with a malignancy and admitted to receive a first chemotherapy cycle 
at the Children’s Cancer Hospital in Cairo, Egypt. The parents were approached 
twice, first prior to their child’s first chemotherapy cycle and then again before 
the third. Among the 313 eligible parents, 304 (97%) answered the first 
questionnaire, and 281 (92%) the second one. 
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twice, first prior to their child’s first chemotherapy cycle and then again before 
the third. Among the 313 eligible parents, 304 (97%) answered the first 
questionnaire, and 281 (92%) the second one. 
 
!Results: We found that parents reported a higher degree of trust in the medical 
care provided (RR 32.0; 95% CI 15.2-67.7) when they were met with care by 
their child’s physician. Having received information concerning the disease (RR 
13.2; 95% CI 7.8-22.3) and treatment (RR 17.2; 95% CI 9.5-31.4) resulted in 
higher trust in the health care and the physicians. Also, we found that 72 percent 
(n=219/304) of the parents had their child’s disease disclosed by the physician. 
Among those, 39 percent (n=85/219) of the children were present during the 
conversation. Less than half of those children (45%) were below the age of 5. 
Also, 68 percent (n=123/181) of the parents reported that their child did not take 
the prescribed medication while at home and the two main predictors reported 
by the parents were child’s resistance (90%, n=111/123) and inadequate 
information provided (81%, n=100/123). Finally, five years after the study was 
conducted, we observed a survival rate of 58 percent (n=176/304) with a 10 
percent lost to follow-up. Among the studied children, we could, however, not 
relate the mortality to any of the psychosocial predictors addressed in this thesis. 
 
Conclusion: Our main hypothesis that the degree of parental trust in the health 
care system and physicians affects the child’s adherence to treatment, dose 
intensity, and thereby the survival rate, was not confirmed. We found an 
association between information provision and how it is provided with trust and 
adherence, yet none of these predictors were associated with the obtained 
survival rates. The observed survival rate of the children in our group is 58 
percent, with an addition of 10 percent lost to follow-up. This is an increase as 
compared to official statistics of earlier years. Adherence to medication while at 
home was associated with parental degree of trust in physicians and health care 
professionals, but not with survival rate. We found an association between 
whether before the child’s first chemotherapy cycle 1) information to parents 
was provided or not, and 2) how it was provided, with the degree of trust 
reported by the parents before the child’s third chemotherapy cycle.  
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1 ! INTRODUCT ION!
As a senior psychology student at the American University in Cairo (AUC) in 
2000, I was asked to join a research group at the university in collaboration with 
the National Cancer Institute in Cairo, Egypt. The assigned research was aimed 
at mapping, comprehending and illustrating the psycho-oncological side of the 
children sick with cancer in Egypt, their families, and the health care situation in 
general and the treating physicians specifically. This was the toughest job I had 
ever undertaken, yet it turned out to be the most scientifically and humanitarian 
fulfilling task I had pursued up to that time. During these years, I came across 
these questions: “Why are those children suffering so much?” “Why is the 
mortality rate in Egypt so high compared to Sweden and the US?” Many 
different answers were provided ranging from “they don’t have equal treatment” 
or “they are not as advanced in medicine as we are in Sweden” and many more 
answers would be provided, none of which ever satisfied my quest.  
During those years, I observed a major obstacle in the communication between 
the children, the health care professionals and the families. Information sharing 
was barely visible, and I saw that well-established relationships between patients 
and physicians simply did not exist. Thus, the confidence that can be created by 
such relationships, relationships I perhaps had assumed would be present, was 
absent.  
For me, this was a strong motivation to go on and pursue additional research. I 
was constantly preoccupied by the fact that so many children are dying every 
year in the cancer hospitals and many more at home that we do not even know 
of. I thought that perhaps the low survival rates were not entirely due to lack of 
appropriate treatment, and that perhaps the child’s psychosocial (psychological 
and social) environment, as shaped by the parents, the extended family, the 
health care system and the physicians, would have an impact. 
At that time, and unfortunately even today, barely any data exists about this 
group. So, in 2005, I decided to conduct a study for my master’s thesis in Egypt 
and find out about children’s and parents’ as well as physicians’ experiences of 
cancer, the social and emotional consequences of having one’s child diagnosed 
with cancer and how it reflects on the child, the family and the health care 
system. The thesis title was “A study of how Egyptian children with cancer, 
their parents and physicians perceive the illness and hospital stay from a health 
psychology perspective”. I had no literature to build on from; therefore, I had to 
start from scratch and use the data I had collected in the preceding years 
beginning in 2000 and ending in 2003. From the material I had collected during 
those three years, I observed several psychosocial issues that appear to interfere 
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with the parents’ well-being, which apparently seemed to influence the child’s 
physical and emotional health.  
Cancer care today often provides up-to-date biomedical treatment but fails to 
address the psychosocial problems associated with the disease. This failure can 
compromise the effectiveness of health care and thereby adversely affect the 
health of the cancer patient. Psychological and social problems created or 
exacerbated by cancer include emotional problems, lack of information or skills 
needed to manage the disease, time-consumimg, long, expensive and exhausting 
transportation, lack of other resources, and disruption in work, school and 
family life. All of these factors cause additional suffering, weaken adherence to 
prescribed treatments, and threaten the patient’s return to health. This was the 
driving force behind my decision to do the research for this thesis since we 
hypothesized that parents who do not have a proper parent–physican 
relationship and receive adequate, comprehensible and concrete information 
about their child’s disease and treatment will not trust health care providers as 
much as the parents who do experience an excellent parent–physician 
relationship. These parents will more likely be late to the treatment appointment 
or may not show up at all as they have not been informed about the significance 
and consequence of not following the chemotherapy regimen on a fixed 
schedule. The more I thought about all of these factors, the more I wondered if 
those unmet psychosocial needs might turn out to be factors associated with the 
low survival rates. Being left with these questions, I decided to seek an 
education in science to find out if and what psychosocial features may partially 
account for the low survival rates that were found at that time in Egypt. 
The pre-study that this thesis is based on is extracted from my 10 years of 
experience in pediatric oncology wards in Egypt and mainly my master’s thesis 
work at Linköping University in 2005, which entailed the data collection 
conducted in Egypt at Cairo’s three major governmental oncology wards. The 
main study, however, was made in 2008 at the state-of-the-art, non-
governmental, and only child oncology hospital in Egypt and the largest in 
Africa; namely the Children’s Cancer Hospital in Cairo (CCHE), which was 
founded in 2007.  
Throughout the research leading to this thesis, during the construction of the 
questionnaires and throughout the analysis and writing-up phase, I had 
interactions with many specialists who became involved. I was fortunate in 
having available a pediatrician, a specialist nurse in childhood cancer, and a 
professor in oncology and epidemiology, all from different institutions in 
Sweden, and all able to contribute their special knowledge. I was also fortunate 
in being able to interact with a pediatric oncologist, a psychiatrist and a 
psychosocial specialist, as well as a professor in oncology from the hospital in 
Egypt. The whole team was a tremendous resource throughout the thesis work. 
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The journey has been long, progress has been achieved to some extent and the 
survival rates luckily seem to be increasing. Yet much more remains to be 
accomplished. Personally, this thesis is a start of a long journey into the 
fascinating realm of knowledge and learning as well as being keen and 
passionate about every child and parent I come across. My passion for those 
children will always be the source of the compelling energy to pursue this 
journey of mine. 
 
Hanan El Malla 
November 10, 2013  
 Gothenburg, Sweden  
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2 !BACKGROUND !
2.1!PEDIATRIC!MALIGNANCIES!!
Cancer is a generic term for a large group of diseases that can affect any part of 
the body. Other terms used are malignant tumors and neoplasms. Childhood 
cancer is not a single disease; there are many different types. Compared with 
adult cancers, childhood cancers tend to have different histologies and occur in 
different sites of the body. One defining feature of cancer is the creation of 
abnormal cells that grow beyond their usual boundaries, and which can then 
invade adjoining parts of the body and spread to other organs. This process is 
referred to as metastasizing. Metastases are the major cause of death from 
cancer [1]. 
Leukemia is the most common type of childhood cancer, representing about one 
third of all cancers in children less than 15 years of age. Leukemia is a condition 
where too many underdeveloped white blood cells are found in the blood and 
bone marrow. Four fifths of childhood leukemias are acute lymphatic leukemias 
(ALL); other types include acute myeloid leukemia (AML) and chronic myeloid 
leukemia (CML). Brain tumors are the most common solid tumors in childhood, 
and make up about a fifth of all children’s cancers. There are many different 
types of brain tumors: medulloblastoma, astrocytoma and brainstem glioma are 
the most common. Neuroblastoma (sympathetic nervous system), 
retinoblastoma (eye), Wilms tumor (kidneys), and hepatoblastoma (liver) are 
most usually found in infants or young children. Other malignancies found in 
children and young adults include lymphomas (Hodgkin and non-Hodgkin 
lymphoma), soft tissue sarcomas (including rhabdomyosarcoma), bone cancer 
(osteosarcoma and Ewing sarcoma), plus a number of other less common 
childhood cancers. Histiocytocis is rare; it is not thought to be a true cancer, but 
in many respects it behaves like one [1]. 
Unlike normal cells, cancer cells do not stop reproducing after they have 
doubled 50 or 60 times. This means that a cancer cell will go on and on and on 
doubling. Furthermore, cancer cells do not obey signals from other cells. 
Something in the cancer cells overrides the normal signaling system. This may 
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Cancer cells do not stick together; they can lose the molecules on their surface 
that keep normal cells in the right place. So they can become detached from 
their neighbors. This partly explains how cancer cells spread to other parts of the 
body [1]. 
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Cancers occur when genetic and environmental factors interact in a multistage 
sequence [2] (Figure 1). In a small percentage (5-15%) of childhood cancers, 
familial or genetic factors are thought to predispose the child to cancer [3,4]. An 
even smaller percentage (<5-10%) of childhood cancer has an identified 
environmental link [3,4]. Although some studies have concluded that genetic 
factors make a minor contribution to most types of cancer [4], the majority (75-
90%) of childhood cancers, however, remain poorly understood and causes are 
unknown [3,4]. There is no doubt that it is a combination of factors acting 
concurrently and sequentially that are involved with any individual case of 
childhood cancer. 
Figure 1. Schematic framework for considering cancer etiology (Based on Anderson LM) 
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cancers represent a small percentage of all cancers, each year more than 175 300 
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deaths annually; thus collectively childhood cancers represent an important 
global public health problem [5]. 
In Sweden, approximately 300 children are diagnosed with cancer every year 
[6]. This figure has not changed since the 1950s. At that time, a child cured from 
cancer was rare; currently three out of four children suffering from cancer 
become long-term survivors. Over the last decade, the greatest success has been 
achieved in the treatment of acute lymphatic leukemia (ALL), lymphomas, and 
renal tumors; more than 80 percent of children are now cured. Until 1970, only 
five percent of children suffering from ALL survived [6]. 
Leukemia and brain tumors are some of the most common cancers in children in 
Sweden. Figure 2 shows the survival rates in percentage from different cancer 
diagnoses in children in Sweden. In all cases, survival rates have improved 
considerably from the 1950s to the present day [6]. 
 
Figure 2. Survival rates in percentage from different cancer diagnoses in children from 1950 
to 2005 (Swedish Childhood Cancer Foundation) 
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In the United States in 2012, approximately 12 060 children under age 15 were 
expected to be diagnosed with cancer and about 1340 children are expected to 
die from the disease (Table 1). Although this makes cancer the leading cause of 
death by disease among US children 1 to 14 years of age, cancer is still 
relatively rare in this age group. On average, 1 to 2 children develop the disease 
each year for every 10 000 children in the United States [1]. Mortality rates for 
childhood cancer have declined by 66 percent over the past four decades, from 
6.5 (per 100 000) in 1969 to 2.2 in 2008. The substantial progress in reducing 
childhood cancer mortality is mainly due to improvements in treatment [5].  
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Table 1. Cancer incidence and mortality in children age 0-14  
Country Total 
Population 
(millions) 
Population 
<14 years  
n (%) 
(millions) 
Cancer 
Incidence 
n 
Cancer 
Mortality 
n (%) 
Worldwide 7 022 1 829 (26) 175 300 96 400 (55) 
Egypt 83.7 26.8 (33) 8 500* 5 950 (70)** 
Sweden 9.1 1.4 (15) 300 75 (25) 
USA 313.8 62.9 (20) 12 060 1 340 (11) 
* An overall estimate by the Children’s Cancer Hospital, Egypt in 2008 
** An estimate according to WHO in 2001  
 
In Egypt, a large uncertainty accompanies statistics for cancer incidence and 
survival. Of the 18 496 new cancer cases with confirmed and registered 
malignancy at the National Cancer Institute in Egypt between January 2002 and 
December 2003, 1 937 (10.5%) were children under the age of 20 years [7]. As 
many as 1 184 (61%) were boys and 753 (39%) were girls, with a boygirl ratio 
of nearly 1.57 [7]. According to Children’s Cancer Hospital, 8 500 children are 
estimated to be diagnosed with cancer in Egypt every year [8]. The new 
Children’s Cancer Hospital had 1 862 admitted cases during 2008, which 
approximately account for one-fourth of all children diagnosed with cancer in 
Egypt 2008 [8]. It is difficult to measure the incidence of childhood cancer 
accurately in developing countries, where cases are often unreported due to 
greater frequency of deaths from infectious diseases and malnutrition [5]. The 
great majority of children, and 80 percent of children with cancer live in 
developing countries [9] and more than 60 percent of the world’s children 
diagnosed with cancer have little or no access to effective therapy [5]. 
Moreover, more than 70 percent of all children diagnosed with a malignancy in 
the developing countries die every year [10]. The geographic and socioeconomic 
inequalities in cancer treatment pose challenges that have only began to be 
addressed [11]. 
There are fifteen specialized pediatric cancer wards spread throughout Egypt, 
but the major ones are in the capital, Cairo. In 2007, the largest pediatric 
oncology hospital in North Africa and the Middle East opened in Cairo, the 
Children’s Cancer Hospital (CCHE). CCHE is a non-governmental hospital, 
offering free of charge health care service to the entire country. The hospital 
currently houses 187 inpatient beds, a 300-500 patient capacity outpatient 
department, a specialized clinical pharmacy, intensive care and bone marrow 
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transplant units, a comprehensive surgery department and multi-specialty 
clinics. CCHE is the only pediatric cancer hospital in Egypt.  
2.1.2 CHEMOTHERAPY, DOSE AND DOSE INTENSITY 
In general, cancer treatment varies from surgical removal of the tumor/tissues 
around it, powerful doses of chemotherapy and/or extensive exposure to 
radiation. Chemotherapy entails the administration of strong drugs that target 
fast-growing cells, medicines that also affect other functions of the body causing 
hair loss, indigestion and other side effects. Radiation treatment, on the other 
hand, use radiation to destroy malignant cells, yet, healthy tissues are also 
damaged. Surgery used to remove the tumor may lead to permanent recovery, 
but undetected malignant cells may already have metastasized to other organs or 
moved from their original location in connection with the surgery. Therefore, 
each treatment type results in a certain level of risk and pain to the child, but if 
the cancer cells are left untreated they will ultimately damage vital organs and/or 
the whole circulation of the body so absence of treatment is not seen as an 
option [12]. 
Cytotoxic chemotherapy involves scheduling a series of treatment sessions at 
which a “cycle” is administered. The time interval between each “cycle” session 
is specific for each patient (e.g. one week, two weeks, three weeks). Each 
treatment “cycle” entails a certain dose, which is based on a calculation of the 
child’s weight and height. A treatment “cycle” is provided during a certain 
period of time, e.g. hours, or days at the hospital where the child is admitted to 
the in-patient unit. Usually, the child is discharged when the treatment “cycle” is 
completed, to be back for the next “cycle” within a planned period of time, a 
week, two weeks, three weeks or more, depending on the specific treatment 
protocol provided to the individual child. Correct dose-intensity is received 
when each “cycle” is administered within the planned time-span. When delays 
occur, it is no longer possible to reach the planned dose-intensity, which may 
result in further complications such as metastases or even mortality [12]. 
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Childhood cancer in Egypt is a growing concern for the society since its 
incidence has been increasing rapidly. The high mortality rate is assumed, in the 
literature, to be due to the inadequate access to medical care in developing 
countries as there are very few hospitals or centres existing in these countries 
with CCHE being an exception to the rule. Lack of education and knowledge of 
health concerns particularly relating to children have delayed many familes from 
seeking medical help and treatment [10]. In addition, lack of transportation for 
the patients or obstacles concerning transportation from rural to urban places 
makes the available health care inaccessible [10]. Moreover, limited 
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accessibility to antibiotics and chemotherapeutic drugs makes the treatment 
ineffective as the treatment in this case is based on availability and not efficacy 
[10]. 
According to the most current published statistics in Egypt, pediatric cancer 
incidence in Egypt is occuring in n=862 (9.4%) of the young population below 
20 years of age [13]. The etiology of cancer is known to be quite vague and 
unspecific, however, there are some theories suggesting that cancer, partly and 
in general, in the Arab World can be due to the factors shown in Table 2 [13]:  
Table 2. Etiology of cancer in Egypt (NCI, Egypt) 
In Egypt the mean age of cancer patients is 48 years, which is two decades 
younger than the mean age of American cancer patients [13]. This is a reflection 
of the young age structure of the Egyptian population, with 33 percent below 
the age of 15 [9] and 50 percent below the age of 20 years [13].  
Usually the child is discharged from the hospital when the chemotherapy cycle 
is completed. If the child does not return to the next planned appointment, the 
hospital’s possibility of contacting the family is limited. Thus, to avoid having 
the child’s next treatment cycle delayed, resulting in a decrease in delivered 
dose-intensity, the family has to be informed of the consequences of a delay, 
which requires proper communication between the health care professionals and 
the family. The level of confidence is challenged when nausea, infections and 
other treatment-related complications occur in the child’s home between cycles.  
Nonetheless, CCHE is assumed to have increased the survival rates of pediatric 
cancer in Egypt. CCHE has resources that were not previously to be found in 
Egypt such as highly advanced up-to-date treatment protocol and a holistic 
cancer treatment offering radiation and surgery and physiotherapy departments, 
and is free of charge and available to everyone. The hospital has an electronic 
journal system and offers high technology up-to-date equipment and treatment 
protocols that correspond to the protocols in the US with modifications tailored 
• Increase in smoking prevalence
• Increase of incidence of hepatitis B and C
• “Westernization” of social and dietary habits
• Lack of physical activity
• Low socio-economic status
• Population average age increase
• Reduction in the incidence of infectious diseases
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for the children in Egypt. Aside from that, the hospital houses a specialized 
clinical pharmacy, intensive care and bone marrow transplant units, a 
comprehensive surgery department and multi-specialty clinics, including a wide 
range of specialists, for example: orthopedics, cardiology, psychiatry, 
ophthalmology, otorhinolaryngology (ear-nose-throat), and neurology. 
According to the latest official 5-year survival rate from CCHE that was 
published in 2012 (Table 3), the survival rates have increased dramatically and 
some have reached the rate in Sweden and the US. Nevertheless, CCHE only 
accommodates one-fourth of all children in Egypt diagnosed with cancer. 
Table 3. Five-year overall survival rate from the Children’s Cancer Hospital, Egypt, in 2012 
Diagnoses/type Survival rates 
Leukemia  
 ALL 80% 
 AML 65% 
Lymphomas  
 Non-Hodgkin 80% 
 Hodgkin 95% 
Brain 66% 
Osteosarcoma 77% 
Sarcomas 70% 
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Pediatric cancer has been characterized to result in suffering, pain, social 
alienation, and, in some instances, even disfigurement [14]. The pain of the 
treatment, the fear of having physical changes such as hair loss, weight gain, and 
infertility affect the child’s body, mind and social relationships and the parents’ 
as well. In addition, treatment of all forms of cancer, including pediatric cancer, 
entails the expenditure of a great deal of money, time and effort, as patients go 
through painful treatments, several hospitalizations, changes in physical 
appearance, financial pressures (though the treatment is free of charge, the 
parents are forced to take unpaid leave from work) and even changes in their 
relationships with their parents, siblings and peers.  
Cancer is stigmatized in Egypt, where there are many misconceptions associated 
with having cancer. Most people think that cancer is a death penalty. In addition, 
when a young child is diagnosed with cancer, in most cases, the surrounding 
society may take a side, not allowing the neighboring children or cousins to play 
with the child or to visit the family so as not to be “infected” with the disease. 
Other forms of stigmatization may be a “bad” reputation of not being able to 
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marry in the future due to the assumed infertility that many believe the treatment 
will bring about or due to assumption that cancer runs in generations and there is 
thus a risk associated with marrying into the family of a sick child. 
Unfortunately, there is no published literature in international journals on this 
part of the world that address the stigma of childhood cancer. Thus, I can only 
address my experiences from the hospitals where I have conducted several 
studies. 
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The diagnosis of a child with cancer is extremely disruptive to the family and 
creates a crisis even in the most balanced family. The diagnosis and treatment 
changes the daily life of the child and other family members and have an impact 
on their physical and psychological well-being. It also lowers the child’s self 
esteem, distances the child from peer groups and therefore requires help, in 
many cases, of a psychologist. 
The term “psychosocial health” refers to being mentally, emotionally, socially, 
and spiritually well (Figure 3) [15]. Attending to the psychosocial needs of 
patients should be an integral part of quality cancer care [16]. Meeting the 
psychosocial health needs of a patient is usually referred to as providing 
psychosocial health services, defined as “psychological and social services and 
interventions that enable patients, their families, and health care providers to 
optimize biomedical health care and to manage the psychological/behavioral and 
social aspects of illness and its consequences so as to promote better health” 
[16]. 
Figure 3. Defining“psychosocial health” (Donatelle RJ et al.) 
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The European Society of Paediaric Oncology (SIOPE) has set standards in 2009 
for pediatric psychosocial care [17]. The standards state that psychosocial 
support is an integral part of treating children and teenagers with cancer and of 
their families; also, psychosocial care requires the team to help the patients and 
their families through all procedures, treatment and palliative care where 
nessessary, helping them to cope with the stress involved, pre-empting the 
potential for crisis and attempting to maintain a good quality of life throughout 
[17]. Furthermore, each child or young person with cancer and his or her family 
should be offered psychological help by a psychologist, social worker and 
teacher/play therapist [17]. The quality of life of the child and the family can be 
greatly improved by social, psychological and educational care, communication 
of information about the disease, its treatment and impact on the family, 
information provided to children that is appropriate to their level of 
understanding, maintenance for the child to remain active and continue life as 
normal as possible, helping the child to reintegrate into school and society in 
general, once treatment is completed [17]. Besides information provision about 
disease, treatments, help in coping with emotions accompanying disease and 
treatment, help in managing the disease and assistance in changing behaviors to 
minimize impact of disease; psychosocial needs can also be in the form of 
material and logistic resources such as transportation, help in managing 
disruption in school and family life and financial advice and/or assistance [16]. 
Many people living with cancer report that their psychological health care needs 
are not well addressed in their care. Throughout diagnosis, treatment, and post-
treatment, patients report dissatisfaction with the amount and type of 
information they are given about their diagnosis, their prognosis, available 
treatments, and ways to manage their disease and health [16]. Health care 
providers often fail to communicate this information effectively, in ways that are 
understandable for the parents and that can enable action by parents [18]. 
Moreover, individuals diagnosed with cancer often report that their providers do 
not understand their psychosocial needs, and they do not consider psychosocial 
support as an integral part of their care [16]. 
Most studies on children and cancer in Egypt have been made from a medical 
perspective. Research conducted from psychological and social perspectives 
deals mainly with sick children from a Western point of view. Studies on 
children with cancer from social, cultural and psychological perspectives are 
rare in the Arab World.  
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The fundamental interaction in health care is the one between patient and 
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delivery, and is the benchmark to which the health care system must align. It 
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pervades each component discussed in this thesis. In the context of this thesis, I 
am addressing the patient–physician relationship as a synomym to the parent–
physician relationship. 
The patient–physician relationship is essential to providing and receiving 
excellent care, to the healing process and to improved outcomes. At its best, the 
patient–physician relationship not only provides access to health care but also 
can promote healing as evidence demonstrates the direct effectiveness of its 
relation to health outcomes [19]. It is therefore important to understand and 
identify the components of this relationship. The emotions and the private, very 
often uncomfortable sharing of information between patient and physician 
require a foundation of mutual responsibilities that include respect, open and 
honest communication, trust and a mutual desire to improve health outcomes 
[19]. The patient–physician relationship may be a therapeutic relationship and 
often includes family members, friends and other health care professionals.  
Cancer treatment involves a relationship between the child, his or her family 
members and the treating physicians and the entire health care professionals. 
The World Health Organization proposed that cancer treatment should involve a 
long-term physician–patient relationship due to the long process of diagnosis 
and treatment [20]. As patient–physician communication and patient satisfaction 
are important elements of cancer care [21,22,23], establishing and maintaining a 
good relationship between the caregivers and the parents of a child diagnosed 
with cancer may bring a wide range of positive outcomes to the parents and their 
child. For instance, a high level of satisfaction with the child’s physician can 
play a vital role in improving the child’s health-related quality of life [24]. The 
role of trust in the medical setting has been acknowledged for many years [25] 
and is generally considered to be a central part of the patient–physician 
relationship [26]. Furthermore, the communication between the health care 
providers and the patient is an important factor affecting the degree of adherence 
[27], when patients understand their physicians they tend to follow their 
treatment regimen and modify their behavior [28]. Adherence is an important 
element in treating patients within the patient–physician relationship, especially 
those with life-threatening diseases such as cancer. Additionally, in a study 
made by Safran et al., trust was found to be a key element in the patient–
physician relationship and older patients who trust their physician were among 
those who complied best with the medical regimen [29]. Also, if the child and 
parents understand their physician, they are more likely to follow the 
physician’s recommendations and the suggested treatment schedule [30], which 
in turn will increase the likelihood of being cured. Providing adequate 
information regarding both treatment and prognosis and having this information 
delivered in a proper manner are actions that may increase trust among parents 
of cancer sick children [31]. 
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2.5.1!COMMUNICATION!APPROACH!
The importance of communication in creating a good patient–physician 
relationship has been reflected in research in a Western context. There are 
several factors, however, that may have an influence on the communication 
between physicians and patients. For example, Ben-Sira proposed that the 
severity of the disease interacted with the physician’s communication style to 
determine the patient’s satisfaction [32,33]. Communication may also be of 
importance in the actual curing process [34]. 
There are several communication styles that increase the patient’s satisfaction 
and as a result increase the level of the patient’s adherence. Affective 
communication is one of the communication styles that has been shown to 
increase the patient’s satisfaction [35]. Proponents of affective communication 
mainly encourage physicians to handle the patient with affect, to treat them as 
human beings and not just as one of the cases they encounter everyday [35]. 
This style also encourages physicians to give enough time to their patients, to 
show interest in them, and to explain to them what is going on [36]. Affiliation 
is also another communication style that is favored by patients. Affiliation 
signifies that physicians show interest, warmth, empathy, and friendliness and 
are genuine with their patients [36]. In one study, patients were most satisfied 
when physicians used affiliation and affective communication while decreasing 
their exercise of power [36].  
Another important aspect of the communication that increased the satisfaction of 
the patients was the use of positive words. Hall et al., state that it is very 
important that physicians become more reassuring and use positive words, while 
sustaining a normal tone [25]. Positive words with a negative tone were more 
favored than negative words with a positive tone [25]. However, it will be more 
essential for the patient that the physician can be warm and show concern (for 
the patient) for their situation when they are providing the patient with the 
information [25]. This behavior would imply that the physician actually cares 
for his or her patient, as the physicians will include a socio-emotional aspect to 
care as opposed to caring only about the physical body [25].  
2.5.2!COMMUNICATION!AS!A!COMPONENT!OF!DISCLOSURE!
Communication is one of the major components of the disclosure of diagnosis 
[37]. Disclosure has been defined as “the act of revealing personal significant 
information that exposes the bearer to the risk of rejection of negative 
judgment” [38]. Communication in disclosure refers to how information is 
disclosed. Communication is also an important element within the physician–
patient relationship [25]. “Medicine is an art whose magic and creative ability 
have long been recognized as residing in the interpersonal aspects of the patient–
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physician relationship” [25]. Such an interpersonal aspect is highly dependent 
on the communication of the physicians. Physicians generally spend more time 
communicating with their patients than examining and treating them as they ask 
about the history of the patient, the medical complaint, and give the diagnosis 
and treatment options [36]. Therefore, even though the motivation of the patient 
to enter the clinic of the physician for the first time is mainly determined by the 
competence of the physician, his or her degree, experience and reputation [25]; 
good communication determines whether patients will continue with their 
physician or not [25,36].  
According to Ben-Sira, most patients are very anxious when they enter the 
physician’s clinic for the first time, as they know very little about their condition 
and the prognosis [32,33]. As a result, patients become more dependent on their 
physicians, and hence they expect their physicians to communicate well with 
them to decrease their anxiety level [32,33]. On the other hand, many physicians 
experience distressing emotions when they deliver difficult news to a patient 
such as diagnosis, prognosis, treatment side effects, palliation and end-of-life 
issues. Ptacek and Eberhardt suggested a model of the stress related to the 
physician’s and patient’s experience associated with bad news [39]. This model 
describes the physician’s anticipatory stress before delivering bad news and 
suggests that the stress level for physicians peaks during the clinical encounter, 
whereas for the patient they peak some time afterwards [39] (Figure 4). This 
model suggests that communication of difficult news is not only distressing for 
the patient, but also for the physician and that physicians need to learn how to 
communicate difficult news. 
Figure 4. Stress experienced by physician and patient in the discussion of bad news (from 
Ptacek and Eberhardt) 
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2.5.3!DISEASE!DISCLOSURE!
Disclosure of the diagnosis to patients with cancer in Egypt is a very 
complicated issue and has not yet been addressed in the literature. In the 
Western countries patient autonomy, informed consent and shared decision-
making are deeply rooted in the health care system that shapes the patient–
physician relationship, whereas these values are not as yet integrated in the Arab 
societies [40,41]. 
A significant percentage of cancer patients in the Arab societies are not made 
personally aware of their disease; physicians prefer to withhold information 
from the patient and disclose the cancer diagnosis to selected members of the 
patient’s family [40,41] or to the patient first at the time when the patient has 
experienced adverse effects of treatment [42].  
A study from Saudi Arabia revealed that physicians express the wish to inform 
patients of the diagnosis but they do not know what to say or how to say it [41]. 
They expressed worries that breaking bad news could evoke fear and anxiety in 
patients and they were also concerned that the patients may not be able to cope 
with the difficult news [41]. In addition, one Turkish study identified the 
relatives of cancer patients as one of the most significant barriers to disclosure 
[43] and another study from Saudi Arabia revealed that relatives of cancer 
patients believed that disclosure of the cancer diagnosis to the patient could be 
harmful and bring about suffering to the patient [40]. These assumptions seem to 
be unrealistic as many children, in the master’s thesis conducted, had reported 
awareness of their disease (an awareness that was mostly withheld from the 
parents, physicians and health care professionals) and believed that they should 
be told the truth. This is addressed by studies that show that children were not 
deceived by the avoidance of talking about their diseases or by untrue assurance 
about their prognosis [44]. This is also in line with what the anthropologist Myra 
Bluebond-Langner addresses in her book; that children are competent social 
actors and may be fully aware of their disease, treatment and consequences even 
if adults may not inform them and they are competent enough to comprehend 
and participate in decisions dealing with their disease [45]. Bluebond-Langner 
also addresses that children’s silence is not out of ignorance but a way to hide 
their feelings and knowledge of dying in order to protect their parents, and 
abiding by what Bluebond-Langner refers to as “mutual pretense” [45]. The 
author means that children are responsive to this pattern of social order, and join 
in the pretense in order to ensure their social acceptance and worth [45]. 
In the master’s thesis conducted, an interesting matter observed and discussed at 
the treatment units is the fear of the disease itself and its name and its 
connotation, which in the end is really actual fear of death and stigma. Although 
no studies have been made of the attitudes of various groups of Egyptians 
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toward cancer it is worth noting some of the popular views one encounters when 
cancer comes up for discussion. First, cancer has always been common in Egypt 
among people of all ages, and it has thus been discussed and brought up mainly 
in movies, and the society has formed a negative idea about it as a fatal and 
incurable disease. This preconception has been passed on from generation to 
generation, as the medical system in Egypt has not yet been developed in ways 
that one might hope for. Also, due to the high mortality rate, the old 
predispositions have been strengthened, as several parents and physicians have 
been close to a person who has died of cancer or have heard of cancer in various 
ways. The fear starts by not mentioning the name of the disease as it may, for 
many people, be a bad omen or bring about distress or fear of becoming 
diseased by it. Thus, when the parents have to say the name, they usually say 
“the bad disease” or “the malignant disease” and straight afterwards they will 
say “may God protect us from it” as if saying or mentioning the disease will 
possibly pass it on to the person.  
The decision of disclosing or withholding information from parents to a child 
with cancer in Egypt is not fully agreed upon by many of the physicians 
interviewed in my master’s thesis. Some physicians favor disclosure, some are 
uncertain while others do not find it essential or they do not know how to 
practice it. The nature of cancer and its association with death and other 
misconceptions make some physicians reluctant to tell the child’s parents when 
they are suspecting a cancer or even when they are sure of it. The severity of the 
disease and the stage reached dramatically changes the physician’s decision as 
most of them withhold such information from the parents. The dilemma of 
deciding the optimal methods for telling children bad news about their own 
cancer remains unanswered [46] and in Egypt, the decision of truth telling in 
general remains undisclosed and neglected due to the general preconception that 
it is not in the favour of the child.  
2.5.4!ADHERENCE!TO!MEDICAL!REGIMEN!
Non-adherence to medical regimen is a concern in pediatric malignancies 
throughout the world, not least in the developing countries [47]. It is one of the 
major complicated issues in the pediatric oncological setting.  According to the 
definition of the World Health Organization (WHO) in 2003, which is an update 
of the first definition addressed by Haynes in 1979, adherence is “…the extent 
to which a person’s behavior-taking medication, following a diet, and/or 
executing lifestyle changes, corresponds with agreed recommendations from a 
health care provider” [48]. Hence, the patient and his or her family are 
responsible to follow and maintain the prescribed regimen as agreed upon. In 
addition, the role of the health care professionals in providing clear information 
and explanation of the treatment options is emphasized [48]. Cessation, refrain 
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from or incorrect intake of cancer treatment in children can bring about serious, 
often life-threatening health outcomes as well as severe economic outcomes for 
the individual and the wider society [28,29]. It can adversely restrict the cost-
effectiveness of medical care and affect the health and quality of life of the 
patients. Increased health care costs (extended treatment, additional physician 
visits, changed prescriptions), and the development of drug-resistant organisms 
are common outcomes of non-adherence [29,47,48]. In addition, non-adherent 
patients report poorer quality of life, increased suffering from disease, increased 
hospitalization time and increased morbidity and mortality [29,48].  
Adherence can be divided into three age categories: infants, young children and 
teens as the characteristics of the child’s life and behavior are likely to affect 
why they may be non-adherent to treatment [49]. As children become more 
autonomous, adherence tends to become more difficult to maintain. The 
tendency of children to run away at the time of cancer drug administration 
makes adherence difficult in young children [49]. Furthermore, adolescents’ 
oppositional behavior and wanting to be like their peers may be predictors of 
non-adherence [49]. Despite the dangerous nature of pediatric cancers, between 
10 to 50 percent of children and adolescents with cancer fail to adhere to oral 
medication regimes [50] and one study showed that between 27 and 63 percent 
of adolescent patients did not follow the prescribed oral treatment [51]. Very 
little is to be found in the international literature from Egypt or the Arab region 
regarding the importance of and the leading causal factors of non-adherence and 
the serious life threatening consequences as well as economical consequences of 
such a malpractice.  
Children’s suffering during their hospital stay may be reflected in their behavior 
when at home as children reflect their fear, apprehension and anxiety in both 
behavioral and physiological reactions [52]. Resistance and throwing tantrums 
becomes a daily pattern in the child’s life, at home or in the hospital as a 
response to the perceived anxious situation they are in [52]. A number of studies 
have found several variables associated with poor adherence [48]. Adolescents 
and in particular males are more likely to be non-adherent [48]. Lower socio-
economic status of the family in general and lower parental education level and 
parental separation have all been associated with non-adherence [48]. In 
addition, less knowledge about the disease and treatment has, in many studies, 
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duration, course of treatment and disease severity have been found in the 
literature to be associated with adherence [48]. Positive adjustments in terms of 
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3 !A IM!
The aim of this study was to investigate psycho-oncological predictors of 
mortality, parental perception of the care their child receive as well as of the 
health care professionals they met, in order to improve care of children with 
cancer.  
Specific aims of the research for this thesis: 
1. Identifying psychosocial predictors of mortality in pediatric malignancies.  
2. Investigating a five-year mortality rate in relation to psychosocial 
predictors. 
3. Investigating the degree of adherence to prescribed medical regimen upon 
discharge and predictors of non-adherence. 
4. Identifying the degree of information sharing about disease and treatment 
and its relation to parent’s degree of trust in the physician, the health care 
professionals and the health care system. 
5. Examining the rate and pattern of disease disclosure to parents and 
children. 
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4 !PAT IENTS !AND!METHODS !
4.1!STUDY!POPULATION!
The study population for the research of this thesis comprised all parents 
(n=313) of children newly diagnosed with cancer admitted to receive a first 
chemotherapy cycle at Children’s Cancer Hospital in Cairo, Egypt (CCHE), 
Egypt, during a study period of 7 months (February until September 2008).  
4.2!CONSTRUCTION!OF!QUESTIONNAIRES!
During an 18-month phase (2007-2008), we constructed the two study-specific 
questionnaires (Pre-1 and Pre-3) according to procedures developed at the 
Division of Clinical Cancer Epidemiology [53,54,55] integrating qualitative and 
quantitative methods as described below: 
1. Qualitative pre-study based on master’s thesis material 
2. Interviews with study population; parents of children newly diagnosed 
with a malignancy 
3. Assignment of the content of the interviews to categories 
4. Construction of questions based on the information from interviews 
5. Face-to-face validation (the questions are tested on the intended 
population) 
6. Pilot study (questionnaire administered to a small number of 
individuals) 
7. Questionnaire administered to the entire population 
4.2.1!QUALITATIVE!PREFSTUDY!
My master’s thesis data collection was performed during 2005 and entailed 
formal and informal interviews with children, parents, and physicians in 
addition to informal interviews with the child’s relatives, health care 
professionals present at the unit and individuals close to my informants. The 
data collection also entailed participant observations in the hospital setting 
where the patients and the parents and the health care professionals were 
observed and notes were taken on those observations.  
In the research, I adopted a qualitative research method of data collection used 
in psychology; Interpretive Phenomenological Approach (IPA), common in 
critical health psychology. The Interpretive Phenomenological Approach 
method was developed to provide a closer look at the person’s psychological 
world in relation to social and cultural context [56]. Interpretive 
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Phenomenological Approach is concerned with health psychology as it 
presupposes a bond between cognition, physical state and verbal response [57]. 
As my research deals with the ideas, beliefs and thoughts of the child and parent 
and physician at the oncology hospital, this method has been used in order to 
understand how these three participants view and experience life, death, the 
disease, the hospital stay and their world as a whole. The method does not 
question the individual’s thoughts and ideas and view of the world as true or 
false, rather it aims at finding how individuals experience certain things [56]. It 
also acknowledges the fact that the individual’s experiences, thoughts and 
feelings about things in life evolve from human interaction with the social 
surroundings [56]. The IPA method has an advantage in producing a cognitive 
“map” to the researcher that entails the informant’s view of their situation [56]. 
In the master’s thesis, some analytical techniques have been used from the 
Grounded Theory since it is very closely related to Interpretive 
Phenomenological Approach. Grounded Theory has broad data collection 
options in terms of transcription of audiotaped semi-structured interviews, 
participant observations, memo writing, and making use of a “focus group” [56]. 
The two approaches are very similar to each other as they both are concerned 
with “themes and categories” that arise through analysis [56] and this is what 
my research has been concerned with. Furthermore, they both entail 
“comparison” of the information and their meanings [56] which is indeed a very 
important theme in the process of analysis. 
Three different formal interviews based on minor questionnaires were conducted 
and different interview guides were elaborated. A consent form was filled in for 
all children, parents and physicians that participated. I interviewed and observed 
69 children and their parent/caregiver (in some cases I was able to see both the 
mother and the father and grandmothers and other relatives during the visiting 
hours) and 21 physicians. 
The interview questions were translated into colloquial Egyptian. All formal 
interviews were audiotaped and transcribed in extensor to English as they are 
audited in Arabic. The transcriptions are not detailed in the sense that I did not 
include non-linguistic features. Thus, the transcriptions were the conversation; 
the words being said, nevertheless, I would include pauses and repetitions as I 
found them important to my analysis. It is vital to add that the transcriptions 
were not my understanding of the conversation but a direct translation into 
English. Moreover, some of the translations of metaphors or idioms were later 
translated into the context of English, which entails my own understanding of 
them from my experience of the country.  
Furthermore, important themes were then extracted from each interview (child, 
parent and physician). Then, I would group the most common themes from the 
parent, child and physician and place them in categories, as I would refer to 
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them throughout my analysis. I also made several observations. The 
observations entailed spending hours on meetings with the physicians, children 
and their caregivers on a daily basis during my stay. Also, observations were 
made in other settings such as in the pediatric outpatient clinics, homes, and 
various social assemblies, attending lectures, hospitals rounds and funerals. 
Also, detailed accounts were made of interactions between the child and parents, 
physicians, nurses, relatives, visitors, strangers, and in various settings, such as 
the clinic waiting rooms and treatment rooms e.g for MRI, CT scan, and 
Radiotherapy.  
4.2.2!INFDEPTH!INTERVIEWS!
As a final step prior to the construction of the two questionnaires, additional 
interviews were conducted as open-ended and semi-structured questions. We 
conducted 29 in-depth interviews in 2007 at the oncology wards in three 
governmental hospitals in Cairo, Egypt. We followed the same analysis pattern 
as in the work for the master’s thesis. We grouped the main concerns that the 
parents reported during the interviews conducted in 2005 for the master’s thesis 
and the in-depth interviews conducted later. We set up our hypotheses and 
divided the questionnaires accordingly. The main categories reported by the 
parents were: lack of the provision of proper information, cancer disclosure 
concerns, and what information was provided during those critical 
conversations, a wish for involvement in the care of one’s child, child resistance 
to treatment at the hospital and at home, unmet emotional needs, lack of 
confidence in the health care system, the health care professionals and the 
treatment and the fear of death of one’s child.  
4.2.3!CONSTRUCTION!AND!CHOICE!OF!QUESTIONS!AND!RESPONSE!
SCALES!
For questions like ”Overall, how would you rate the care your child receives at 
the hospital?” we used a response scale including the categorics “very bad”, 
“bad”, “moderate”, “good”, and “very good”. We also used attitude scales where 
we asked “Sometimes your child’s physicians do not pay full attention to what 
you are trying to tell them, do you agree?” with the response scale “Do not agree 
at all”, “Agree to some extent”, “Agree to a large extent”, “Agree completely”. 
Furthermore, person-prevalence scales were used in questions like “How often 
do you consider that your child’s physicians have provided you with sufficient 
time?” with the response scale “Never”, “Rare”, “Often”, “Always”. Person-
duration scales were also used in questions like “For how long did your child’s 
symptoms last until your first contact with a physician?” with the response scale 
“A few days”, “A few weeks”, “A month”, “2-3 months”, “Four months up to a 
year”, “One year or longer”. Intensity scales were used for questions like 
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“Overall, how much do you trust your child's physician?” and “How much 
information have you received about your child's disease?” and “How much 
information have you received about your child's treatment?” For these, there 
were four answering categories “None”, “A little”, “Moderate”, and “Much”. 
For categorical variables measured with questions like “Do you feel that the 
physicians gave you the chance to express your thoughts and concerns?”, there 
were only two answering categories “Yes”, “No”. Some questions concerning 
the parents, for example if they had received recommendations upon discharge, 
whether or not the recommendations had been followed, and if the parents found 
the given recommendations relevant and manageable the response alternatives 
were: “Yes” and “No”. If any of the recommendations had not been followed, 
the parents were given five options to provide information on why they had not 
been followed.  
Starting with about 150 questions originating from the interviews, we gradually 
reduced the number of questions excluding those that resembled one another 
until we had 89 (Pre-1) and 90 (Pre-3). 
4.2.4!VALIDATION!OF!QUESTIONNAIRES!!
To ensure that all questions and answer alternatives were relevant and easy to 
understand, face-to-face interviews were conducted with 28 parents of children 
newly diagnosed with cancer at the pediatric oncology wards. The primary aim 
at this stage was to determine if there was any essential data we had missed 
(validation of content). Face-to-face validation also gave us the chance to see if 
some questions or alternative questions were unclear or differently understood 
by different individuals (validation of interpretation). In order to ensure that 
neither the subjective opinion of the interviewer nor the comparable opinions of 
others in the research group would alone guide the choice of question 
formulation and alternative answers, we encouraged the study population to 
choose between similar questions and similar alternative answers (validation of 
choice).  
The questionnaires were constructed in English by the team in Sweden, and 
were then translated into colloquial Egyptian and then back translated to assure a 
correct and accurate colloquial translation. The questionnaires were translated 
by a translation company and edited subsequently during the several interview 
phases. 
4.2.5!PILOT!STUDY!
The questionnaires were validated in a pilot study comprising 54 parents of 
children newly diagnosed with cancer. The pilot study was conducted at the 
same three governmental hospitals. During this study, we tested the data 
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collection logistics, estimated a likely participation rate and checked whether 
some questions were left unanswered.  
We ended up with two study-specific questionnaires; Pre-1 administered prior 
to chemotherapy treatment cycle 1 and Pre-3 prior to chemotherapy treatment 
cycle 3. In addition, a Case Report Form (CRF) was attached to each 
questionnaire. The CRF contained the following information: child’s name, 
address, name of parent, age, gender, length, weight, diagnosis, date of 
interview, scheduled chemotherapy treatments, medicine received and dose.  
The questionnaires (Pre-1/Pre-3) contained 89 and 90 questions respectively 
and were divided according to the following topics; Pre-1: socio-demographic 
data, cancer diagnosis, family history, the amount of information provided about 
disease, treatment, and most common side effects of treatment, hospital stay 
experience, diagnosis disclosure, communication with physicians and health 
care professionals, and psychosocial and emotional experiences. Pre-3: reasons 
for delay to medical treatment, information provided by health care 
professionals, investigations, hospital stay experience, next treatment cycle 
attendance, adherence to medical treatment at hospital and home, psychosocial 
and emotional experiences, and trust in physician and other health care 
professionals as well as the medical care.  
The questionnaires were marked with a serial number on the back and could 
only be decoded by the researcher. 
4.3!METHODS!OF!DATA!COLLECTION!
All parents in our study population were approached at the daycare center or at 
the pediatric oncology ward on the day they came to the hospital to start their 
child’s first chemotherapy cycle, which was considered our baseline. They were 
informed about the study, asked to give their consent to participate, and, if they 
agreed, asked to fill in our first questionnaire (Pre-1). The same parents were 
subsequently approached and asked to complete the second questionnaire (Pre-
3) when their child came to start the third chemotherapy cycle. We excluded 
parents to children admitted for surgery and radiation therapy, as they did not fit 
the inclusion criteria. Due to the high illiteracy level in Egypt, the study team 
decided to have an interviewer administer the questionnaires; reading the 
questions out loud and then filling in the spoken answers by writing the answers 
in the questionnaire.  
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4.4!DATA!ENTRY!
Data were manually entered into Epidata version 2.0 and 20 percent of the 
questionnaires were re-entered to check accuracy. The program is pre-
programmed to identify possible false entries, like inappropriate values, in order 
to minimize bias. All doubtful answers such as double-marked, written notes on 
the side were referred to the principal investigators. Having an interviewer 
filling in the questionnaires, significantly reduced errors such as wrong marks or 
missing a question. Furthermore, 45 randomly chosen questionnaires were re-
entered to test the reliability of data entering. 
4.4.1!STATISTICAL!ANALYSES!
The relative risks (RR) with corresponding 95 percent confidence interval were 
calculated as the ratio of the percentages of each category of the independent 
variable using the SAS procedure freq with option relrisk. For calculating 
adjusted relative risks with corresponding 95 percent confidence interval, a log-
binomial regression model was performed. To find predictors for an outcome, 
we included possible variables in a model, and automatic selection was 
performed utilizing the SAS procedure logistic with selection options backward 
and forward and default settings. As a complement, we also performed model 
selection using Bayesian model averaging (BMA) on imputed datasets created 
with multiple imputation by chained equations (MICE). Also, we used Chi-
square goodness of fit test or, where appropriate, Fisher’s exact test, to produce 
a P value that illustrates whether there is a difference in proportions between 
two groups. A P value below 0.05 was considered to indicate statistical 
significance. For BMA, a posterior probability of 95 percent indicates a strong 
evidence for association. 
All statistical analyses were performed by a statistician using software SAS 
version 9.3 for Windows (SAS Institute Inc., Cary, NC, USA) and two packages 
(MICE/BMA) in the freeware R (R: A Language and Environment for Statistical 
Computing; 2005). See manuscript I-IV for details of statistical analyses in each 
study.  
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Among the 313 eligible parents, 304 (97%) answered the first, and 281 (92%) 
the second questionnaire (figure 5). The study population comprised one parent 
of every child. Five years after the study was conducted, we had a survival 
follow-up and we found that 58 percent (176/304), with an additional 10 percent 
(n=30) of lost to follow-up, were alive (Figure 5). For further details of the 
study group’s characteristics, see Table 1 in Paper I-IV. 
Figure 5. Study population 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
* One parent of every child 
** ICU: Intensive Care Unit 
 
The majority of children had both parents as primary caregivers (84%), but the 
mother was the accompanying parent during the hospital stay (81%). One-third 
of the mothers (35%) and the fathers (32%) did not have any education, whereas 
about 10 percent had a university degree. The vast majority of the mothers 
(90%) were housewives, and the fathers were laborers (67%). Most of the 
families lived in rural areas (66%). 
313 eligible parents of children diagnosed with 
cancer, fitting our inclusion criteria; admitted to 
hospital for their child’s first chemotherapy treatment* 
Pre-1: 304/313 (97%) participants 

Pre-3: 281/304 (92%) participants 

Drop-out (n=9, 3%): 
     Declined participation: (n=5)  
     Child admitted to ICU** upon arrival (n=4) 

Drop-out in children (n=23, 8%):  
Between 1st and 3rd treatment cycle: 
     Died (n=13) 
     Palliation (n=4) 
     Shift of treatment to pills at home (n=1) 
     Did not show up to treatment (n=5) 
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5.2!PAPER!I!
The basic goal of the research for the first paper was to investigate predictors of 
trust in the health care professionals and the medical care as reported by the 
parents of the children diagnosed with cancer. Parents’ trust in the medical care 
at the time of the child’s third chemotherapy cycle was significantly associated 
with the following at the start of treatment: having received at least moderate 
information about the disease (RR 13.2; 95% CI 7.8–22.3) and the treatment 
(RR 17.2; 95% CI 9.5–31.4), having the information provided in an adequate 
manner (RR 13.7; 95% CI 7.8–24.1), having the opportunity to communicate 
with the child’s physicians (RR 21.3; 95% CI 11.7–38.8), being given the 
chance to express thoughts and concerns with the physician (RR 5.9; 95% CI 
2.9–12.1) and with the nurses (RR 4.8; 95% CI 2.4–9.5), being satisfied with the 
physician’s conversation style (RR 30.6; 95% CI 14.4–64.9), having the 
emotional needs met (RR 22.2; 95% CI 11.8–41.9), and being met with care by 
the child’s physicians (RR 32.0; 95% CI 15.2–67.7). After adjusting for all 
independent variables addressed above, using forward and backward stepwise 
regression, six independent variables remained to explain our main outcome 
(trust in the medical care provided to the child): information received about the 
child’s disease (P=0.0251), information received about the child’s treatment 
(P=0.0064), opportunity to communicate with the child’s physicians 
(P=0.0203), being satisfied with the conversational style of the child’s 
physicians’ (P<0.0001), perception that the child’s physicians were sensitive to 
the parent’s emotional needs (P=0.0031), and finally considering that the child’s 
physicians had met the parent’s with care (P<0.0001). However, by using a 
more strict model selection according to BMA, only one of the independent 
variables fulfilled the posterior probability limit of strong association (>95%), 
namely regarding that the child’s physicians had met the parents with care 
(95.4%). Among parents who were met with care by the child’s physicians to 
only a little or no degree at the start of treatment, not a single parent reported 
much degree of trust in the medical care provided at the time of the third 
chemotherapy cycle. 
5.3!PAPER!II 
The goal of the research for the second paper was to address the rate and pattern 
of disease disclosure to parents of children newly diagnosed with cancer at the 
Children’s Cancer Hospital in Egypt. To do this, we examined in some detail the 
nature of disease disclosure at the time of the first chemotherapy treatment, 
when the child has already been diagnosed and is about to start chemotherapy 
treatment. We found that nearly three quarters (72%) of the parents had their 
child’s cancer diagnosis communicated by the physician. Only 39 percent of the 
children were present during the disease disclosure conversation. The majority 
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of the children were between the age of 5 to 18 (55%) and 45 percent were 
between 0 to 4 years old. During disease disclosure, physicians used “tumor” 
(the Arabic word is waram/swelling) most commonly to describe the disease 
(n=292). The second most common term used was “difficult disease” (n=161) 
whereas “malignant disease” (n=31) and “cancer” (the Arabic word is saratan) 
(n=18) were less frequently used terms. The majority of the physicians stated 
the cause of the child’s malignancy as “unknown” (n=110), or due to “divine” 
reasons (n=100). A few parents were also given the information that their 
child’s disease was caused by “heredity” (n=8) and “environmental factors” 
(n=1). There were no statistically significant associations between psychosocial 
and demographic characteristics and by whom the disease was disclosed. 
5.4!PAPER!III!
The aim of the research on which the third paper was based was to investigate 
the rate and pattern of adherence and the predictors of non-adherence to the 
medical recommendations that are provided to the parent and child upon 
discharge. More than two thirds of the children admitted to their third 
chemotherapy treatment received medical recommendations upon discharge 
from their second chemotherapy treatment. In the studied population, which had 
a total of 281 parents after drop-out between the two questionnaires; 64 percent 
(n=181/281) of the parents had reported that they received medicine to take 
home upon discharge between the first and/or second chemotherapy treatment. 
No statistically significant differences were found between the two groups of 
parents who followed (n=58/181, 32%) and who did not follow (n=123/181, 
68%) the medication plan except for an increased adherence among children of 
educated mothers (P=0.017). Among the adherent children’s parents, 88 percent 
(n=51/58) reported difficulties following the recommendations, whereas almost 
all parents (n=56/58, 97%) thought the recommendations were relevant. 
According to the parents’ reports, n=111/123 (90%) of the children who 
received medical recommendation upon discharge refused to take the provided 
medicines while at home. Furthermore, 81 percent (n=100/123) of these parents 
reported that the information provided upon discharge was insufficient. In 
addition to our data reported in the manuscript, an additional finding was found 
in a comparison of the adherent and non-adherent parents at the time of their 
child’s third chemotherapy. We found a statistically significant difference 
concerning reported knowledge about the child’s disease (adherent 48/58, 83%, 
and non-adherent 82/123, 67%, P=0.02). On the other hand, no statistically 
significant difference was found between the groups’ reported knowledge about 
treatment (adherent 52/58, 90%, and non-adherent 102/123, 83%, P=0.24) 
(Figure 6).  
In the adherent group one out of five parents (n=12/58, 20%) reported trust in 
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their child’s physician while 8/58 (14%) reported trust in the other health care 
professionals. Corresponding numbers for trust among non-adherent were 8/123 
(7%) for both the child’s physician and other health care professionals. Nearly 
all parents (n=122/123) who received medical recommendations upon 
discharge, but who were non-adherent, reported an intent to attend their child’s 
next chemotherapy treatment cycle, although the majority in this group did not 
consider the treatment to be of any use, n=180/277 (65%). After adjusting for 
seven independent variables to explain the parents’ intentions to pursue the next 
chemotherapy treatment cycle, two independent variables were left to explain 
that outcome: doing so for the sake of their child’s life (70%) (P=0.005) and 
worry that their child would die if they discontinued the treatment (81%) 
(P<0.0001). No parent had been involved in the decision making regarding the 
child’s treatment or hospital care and 94 percent (n=266/281) of the parents 
reported that they had no or little knowledge about their child’s disease and 
treatment. Nine independent psychosocial and emotional predictors were 
identified and included in a model. The risk of not having the psychosocial and 
emotional needs met in the non-adherent group was almost double the risk in the 
adherent group. Furthermore, the non-adherent group of parents reports the 
situation as being more than five times more difficult to manage than those who 
adhere. 
Figure 6. Adherent and non-adherent parents’ reported knowledge about disease and 
treatment at the time of their child’s third chemotherapy cycle 
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The overall aim of the fourth paper was to investigate predictors of mortality in 
pediatric malignancies and to investigate the present mortality rate at the 
Children’s Cancer Hospital in Cairo, Egypt after a five-year follow-up in the 
study group. We considered the various psychosocial predictors addressed in the 
questionnaires such as late to treatment, adherence and non-adherence to 
medication, trust and information provided. We also considered BMI, age, 
gender, and diagnosis and residence area. Five years after the study was 
conducted, we found that 58 percent (n=176) of the children had survived the 
first five years after treatment initiation (Figure 7). Thirty children (10%) had no 
current active status at the hospital, and therefore, are lost to follow-up. The 
majority of the children were in the age group 0-4 years (44%) and males (59%) 
dominated. The majority of these children had a leukemia (n=131) followed by 
lymphoma (n=49), neuroblastoma (n=28), sarcomas (n=25) or brain tumor 
(n=17). The leukemia (73%) and lymphoma (73%) patients had the best 
prognosis.  
Figure 7. Survival among children followed up for five years 
 
 
 
 
 
 
 
 
 
* The survival rates are likely to be between 58% and 68% due to 10% of lost to follow-up  
Moreover, we found a statistically significant difference in the mother’s level of 
education between the group that survived and the group that died (Table 4). No 
statistically significant differences were found between the groups in relation to 
Pre-1: 304 children 
Pre-3: 281 (92%) children 
Drop-out (n=23, 8%):  
Between 1st and 3rd treatment cycle: 
     Died (n=13) 
     Palliation (n=4) 
     Shift of treatment to pills at home (n=1) 
     Did not show up to treatment (n=5) 
176 (58%) survivals* 
Lost to follow-up (n=30, 10%)* 
Died (n=98, 32%) (in total 
throughout the study) 
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several demographic factors such as age, gender, BMI, residence, the father’s 
level of education and occupation of both parents (Table 4). 
Table 4. Demographic factors versus survival/non-survival  
Demographic factor No./total no. (%) P value* 
Gender   
 Male 103/163 (63) 0.66  Female 73/111 (66) 
Age   
 0-4 78/124 (63) 
0.08  5-8 39/57 (68)  9-15 46/79 (58) 
 16-18 13/14 (93) 
BMI   
 Normal 102/148 (69) 
0.57  Underweight 37/59 (63)  Overweight 10/16 (63) 
 Obese 12/15 (80) 
Geographical area   
 Urban 61/90 (68) 
0.57**  Rural 113/180 (63) 
 Abroad 2/4 (50) 
Mother’s level of education   
 University 58/75 (77) 
0.02  Non-university 65/106 (61) 
 No education 53/93 (57) 
Father’s level of education   
 University 58/78 (74) 
0.09  Non-university 65/104 (63) 
 No education 52/89 (58) 
Mother’s occupation   
 Employee 11/16 (69) 
0.68**  Laborer 7/11 (64)  Own business 0/1 (0) 
 Housewife 158/246 (64) 
Father’s occupation   
 Employee 43/57 (75) 
0.16  Laborer 117/186 (63)  Own business 6/12 (50) 
 Unemployed 8/15 (53) 
* Chi-square goodness of fit test 
** Fisher’s exact test 
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The validity of a study refers to the extent to which the effect measures 
correspond to reality. I have made an effort optimizing the validity of the effect 
measure in this thesis. “The perfect study” does not exist as our real-life studies 
are flawed by either systematic errors, which introduce bias, or random errors 
that influence the precision of the study. At our division we utilize 
epidemiological methods for study design and data interpretation adapted to the 
cancer field according to the hierarchical step-model for causation of bias 
[53,54,55]. This model describes how the final, adjusted effect measure deviates 
from the “perfect study”, the counterfactual situation. The model proceeds in 
four steps from the “perfect person-time” towards a calculated, often adjusted, 
effect parameter (Figure 8). 
Figure 8. A hierarchical step-model for causation of bias applied to our study 
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In the hierarchical step-model, the counterfactual situation is described as the 
“perfect person-time”. For obvious reasons, this situation is unattainable; 
therefore we strive to find an appropriate “targeted person-time” that would 
support valid conclusions. Shifting from the “perfect person-time” to the 
“targeted person-time”, the first step in the hierarchical step-model, introduces 
errors known as giving confounding. Confounding occurs when an effect-
measure deviates from the null due to a factor other than the exposure we study; 
the factor is associated with the exposure and is an independent risk factor for 
the outcome. Having the means to control confounding is of central importance 
for an epidemiological study [58]. In our study, we reduced the risk of 
confounding by including all parents and children newly diagnosed and 
admitted for the first chemotherapy cycle. We also included in our analyses 
several questions on possible confounders such as age, gender, BMI, education, 
occupational and demographic status.  
In paper I, on information provision and trust, a possible confounder for which 
we had no information, is the presence of parents who already display a high 
degree of trust. Such a group could confound the association between the 
parents’ perception and the amount of information provided and hence the 
amount of trust they report. Other possible confounders could be the parents’ 
past experience with health care, for which we have no data, as well as their 
educational level, which showed no statistical significance. In addition, the lack 
of information regarding the parents’ religious beliefs and ethnicity is a possible 
limitation. However, we did not find any associations between regions (as a 
surrogate for ethnicity) or any other socio-demographic factors. In paper II, on 
cancer disclosure, confounding is not a strong issue because the paper is 
descriptive and does not deal with causal relations. In paper III, on adherence to 
prescribed medication, the main confounders we addressed are the amount of 
information provided, educational level, and the parents’ past experiences with 
health care. Yet, we have no data regarding the parents’ past experiences with 
health care. Also, we found increased adherence among educated mothers 
(P=0.017) so, there could be an association but we do not believe the evidence 
is strong enough. Also, we did not find any association between region (as a 
surrogate to ethnicity) and any other socio-demographic factors and thus we 
believe that these factors probably did not confound our reported associations. 
This paper partially supports our main hypothesis that information about the 
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relatively large study-population and a high participation rate (97% in Pre-1 and 
92% in Pre-3), which should reduce the risk of selection-induced systematic 
errors. The dropout between the two questionnaires was due to shift of 
treatment/palliation n=5, death of child n=13 and not showing up n=5). We 
have an additional 10 percent lost to follow-up in paper IV where five-year 
observed survival rates were included. We can only speculate about the 
circumstances among those lost to follow-up. This is a limitation, though it is 
expected in this part of the region where follow-up is not as accurate and 
mandatory as in the Western countries.  
6.1.4!STEP!3:!MISCLASSIFICATION!
Incorrect information due to measurement errors can cause systematic errors 
when shifting from the “observed person-time” to the “data”, the third step in 
the hierarchical step-model. Measurement errors could concern both the 
exposure and outcome under study and can be differential or non-differential. 
Differential misclassification is dependent on and varies with either the 
exposure or the outcome, whereas non-differential misclassification is 
independent of these two measures. Therefore, non-differential misclassification 
is expected to shift the effect measure towards 1.0, i.e. no effect, while 
differential misclassification can affect the effect measure in any direction. We 
tried to diminish the risk of misclassification by repeated interviews with the 
parents of the cancer-sick children who were going through the same type of 
treatment, taking their perspective into account when constructing the 
questionnaires, using simple language and testing the questionnaires for face 
validity, participation rate and response rate to single questions before 
conducting the main study and having an interviewer administering the 
questionnaires. Also, administering the questionnaires right before the initiation 
of treatment and right before the third treatment cycle was believed to control 
for memory-induced problems. However, we cannot avoid the risk of 
misclassification completely. Inadequate entering of data into the computer 
software could result in misclassification, thus, a random selection of 20 percent 
of the questionnaires were re-entered to check accuracy. In paper I, on 
information provision, misclassification can occur due to the over-or 
underestimation when reporting the amount of information received by the 
physician. However, it is more likely to estimate correctly as the questionnaires 
are distributed shortly after the diagnosis is made and right before the first 
chemothreapy cycle. In paper IV where five-year observed survival rates were 
extracted, we could not control for any mistakes that this procedure might have 
brought about when extracting the data. Errors like mistaken classification of 
diagnosis could have also occurred. We had one person extracting the five-year 
survival data and we did not have a re-examiner of the final extracted data that 
might have caused systematic errors. 
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6.1.5!STEP!4:!ANALYTICAL!ADJUSTMENT!
Random errors are conceived as those errors that remain when systematic errors 
have been eliminated. Such errors are unpredictable and have null expected 
value i.e., they are inconsistently scattered around the true value. Statistical 
significance is used to test whether or not a result is likely to have occurred by 
random chance. In our analysis, we considered an effect measure to indicate a 
statistically significant difference when its 95 percent confidence interval did 
not cover 1.0. Moreover, a P value below 0.05 in a statistical test was 
considered to indicate statistical significance. 
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7 !GENERAL !D ISCUSS ION  
7.1!PAPER!I!
To be met with care by the child’s physician at the time of entry to the first 
chemotherapy cycle was the most important predictor for the parents’ 
subsequent trust at the time of their child’s third chemotherapy cycle. In a 
review by Hall et al., it was suggested that patients who trust their physicians are 
more likely to perceive results of treatment in a positive manner, and this in turn 
brings about a more positive view of the future [25]. Trust is thus considered a 
key element for strengthening the patient–physician relationship and also 
ensuring patient adherence with recommendations [59]. Providing high-quality 
information regarding the child’s cancer disease, treatment, and prognosis in an 
understandable and adequate manner has proven to be important for the parents’ 
satisfaction regarding the quality of care [60,61,62,63]. Interestingly, we found 
in our study that the parental trust in the physician and the medical care was not 
related to the amount of information given to the parents of children with 
cancer, after adjusting for factors related to how the information was provided 
and how the parents were regarded during the information sharing. Thus, our 
data indicates that it is the manner in which health care professionals 
communicate, rather than exactly what is communicated, that creates trust in the 
physicians, the nurses, and the medical care. Our results are supported in the 
literature, where the strongest predictor of trust has been reported to be the 
physician’s personality and behavior [25]. Not surprisingly, the physician’s 
conversational style was among those factors that were clearly determined to be 
a predictor of the subsequent level of trust among parents. In other words, it is 
not what you say, but how you say it that matters. To have the opportunity to 
communicate with the child’s physicians was one of the strongest predictors of 
trust in our study.  
Clearly, there is room for improvement regarding patient–physician 
communication. Physicians need to listen to the parents and assess their 
understanding and allow space for silence and questions as part of information 
sharing. Several studies indicate that the majority of the parents of children with 
incurable cancer do want to know the truth about the disease and the prognosis 
[63,64] and that this information by no means make them less hopeful [64]. 
Therefore, it is important that children are properly informed prior to medical 
investigations and treatment initiation. Children, especially, are in need of 
information to help them cope with their imagination and to separate reality 
from fantasy. This information sharing, however, needs to be adapted according 
to the parents’ and the child’s preferences, which in turn depends on the child’s 
age and level of understanding [65]. Having a disrespectful and arrogant attitude 
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and giving information in an insensitive manner negatively affects the level of 
satisfaction with, and trust in, care expressed by parents with children in 
palliative care [31]. Receiving emotional support, not least from the patient’s 
physicians, is considered crucial for patient satisfaction [66]. Indeed, in our 
study, the only factor that remained significantly associated with trust after 
multivariable adjustment was “being met with care by the child’s physicians”. 
In conclusion, our data indicates that it is the way health care professionals 
communicate rather than what is communicated, that creates trust among 
parents. We found that parents who considered that their child’s physicians had 
met them with care at the beginning of their child’s treatment trusted the 
medical care given at the time of the child’s third chemotherapy cycle to a 
significantly greater degree than did other parents. 
7.2!PAPER!II!
We found that nearly three quarters (72%) of the parents had their child’s cancer 
diagnosis communicated by the physician, whereas the rest (28%) had the 
cancer diagnosis disclosed by others. Only 39 percent of the children were 
present with the parent or parents during the disease disclosure conversation. On 
the other hand, 45 percent of the present children were between the age of 0 to 4 
and 55 percent were between the age of 5 to 18. Naming the disease at the point 
of disease disclosure was equally controversial as illustrated by the preference of 
physicians for using the designation “tumor” (n=292). The Arabic word for 
“tumor” ordinarily refers to the presence of a swollen area and is not associated 
with a malignancy/cancer to the same extent as in the Western society. We 
assume that, even if many parents and children may be present during 
presentation of information by the physician, they may not understand what they 
are told or what is really meant by having a “tumor”. 
Barriers to disclosure are many and vary across cultures and societies. Bedikian 
et al. conducted a survey regarding the experience of 249 physicians in Saudi 
Arabia, which revealed that 75 percent of the physicians preferred disclosing the 
diagnosis to close family members rather than the adult patient [67]. Another 
study from Saudi Arabia revealed that physicians expressed the wish to inform 
patients of the diagnosis but they did not know what to say or how to say it [41]. 
They expressed worries that breaking bad news could evoke fear and anxiety in 
patients, which they wished to avoid, and they may also be concerned that the 
patient may not be able to cope with the difficult news [41]. In addition, one 
Turkish study identified the relatives of cancer patients as one of the most 
significant barriers to disclosure [43]. Another study from Saudi Arabia revealed 
that relatives to cancer patients believed that disclosure of the cancer diagnosis 
to the patient could be harmful and bring about suffering for the patient [40]. 
Furthermore, in a cross-sectional study conducted in Pakistan where 147 cancer 
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patients participated, 83 percent (n=63) of the patient’s family members did not 
allow the patient to be informed of his or her diagnosis [42]. Similar attitudes 
were found in a study in Turkey where almost half of the family members 
(130/270) refused to allow disclosure of the disease to the patient [43]. Though 
disease disclosure is controversial, and even though several studies from the 
Arab World indicate that the barriers to disclosure are due mainly to the 
physician’s preferences and/or the relatives of the patients, it is notable that 
nearly three quarters of the parents in our study group were told the diagnosis of 
their child. There has been a positive tendency of improved disease disclosure in 
the Arab World and the attitudes have shifted for as yet unknown reasons. In the 
Bedikian et al. survey of 100 adult cancer patients and next of kin in Saudi 
Arabia in 1984, only 16 percent of the patients were told that they had “cancer” 
and 34 percent were told they had a “tumor” [67]. On the other hand, 69 percent 
of the next of kin were told about the diagnosis of cancer [67].  
The diagnosis of childhood cancer is very dramatic and the associated anxiety 
and stress level are repeatedly addressed in the literature [68,69]. Thus, 
communication ought to take place on several occasions since what is very hard 
to talk about at first may get easier over time, and what can be shared and heard 
at first may expand, as everyone is ready for more detailed information at later 
stages. Furthermore, the variation across nations is great in terms of the 
prevailing cultural assumptions and the ethnic context of the family, the family 
dynamics, the family size, the family structure, the age and educational level of 
the child, as well as the resources and abilities of the parents, the children and 
the health care team involved, all factors need to be taken into consideration 
[68]. Also, children and parents have different needs and we must ask patients at 
each consultation what those needs are [70]. Several studies have addressed the 
patients degree of desire of disease disclosure, such as the study made my 
Butow et al. where 85% of the patients reported that they wanted a large amount 
of detail of their disease and 15% wanted minimal detail [70]. All parents in our 
study group reported a wish for more information about their child’s disease and 
treatment, thus, we argue that even though there might be a variance in desire of 
the degree of information the patient may have, the parents of the child should 
be told all the details of their child’s disease and treatment and they should be 
involved in the decision-making. Moreover, effective communication serves not 
only the patient and family members, but also enables the physician to improve 
the patient’s understanding of his or her disease, improve patient adherence to 
treatment regimen, use time efficiently and avoid burnout [71]. Effective 
communication is responsive to the needs of the whole patient and family 
dynamics; it is essential to patient-centered and family-centered care, the basic 
building block of the medical home concept, which is endorsed by the American 
Academy of Pediatrics (AAP) as a cornerstone of care [72]. Taking time to build 
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rapport and understand the child and family builds trust, leading to increased 
reporting of the actual reason for the visit and influences treatment adherence 
and outcome, adaptation to disease, and bereavement [72]. Clearly, improved 
communication will enhance patient outcomes and satisfaction [72,73].
Considering that truth telling about one’s diagnosis is the first step towards good 
patient–physician communication and the first step for treatment decision-
making in cancer patients, it is evident that common practice in the Arab World 
stands in the way of such communication. Widespread acceptance of full 
disclosure is hardly to be expected in the near future due to cultural differences 
and social dynamics in different regions of the Arab societies and the question is 
if there are regions in these societies where change might take place relatively 
rapidly. However, there is no doubt that there is a need for greater recognition of 
patient autonomy among physicians and the need for developing better practice 
for the disclosure of cancer diagnosis to the patients. Also, to advocate for the 
patient’s ethical rights to know and share in the decision making of his or her 
disease.  
7.3!PAPER!III!
Sixty-eight percent (123/181) of the parents to children who received medical 
treatment upon hospital discharge report that their child did not comply with the 
treatment. In this group, the child’s resistance was the main predictor for non-
adherence as well as lack of information provided to parents. Our findings are 
supported by Kondryn et al., who found that between 27 and 63 percent of 
adolescent patients did not follow the prescribed oral treatment [51]. One third 
(32%) of this group of children was between 9 and 15 years old. Age appears to 
play a role in adherence-related behaviors in children with cancer [50,74]. As 
children grow, behavioral concerns related to adherence may become dominant 
for some children who may actively refuse medication [50]. Also, as children 
become more autonomous, adherence tends to become more difficult to 
maintain [49]. Adolescents usually strive for autonomy and independence and 
usually have limited ability to understand the consequences of their actions, and 
thus they become frustrated with parental authority and the limitation in their 
life due to their disease and treatment, all which may lead to non-adherence 
[50]. Furthermore, adolescents’ oppositional behavior and wanting to be like 
their healthy peers has been documented as a reason for non-adherence [49]. 
Side effects of treatment could be another reason; yet, we have no data from our 
study to investigate such an effect.  
Furthermore, previous studies have found that poor adherence among children is 
mainly due to their own and their parents’ lack of knowledge and understanding 
about the disease and its treatment [48,50]. This goes in line with our finding in 
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about the disease and its treatment [48,50]. This goes in line with our finding in
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this paper, where the adherent group had more knowledge about their child’s 
disease in comparison to the non-adherent group and where the majority of the 
children above the age of 5 had not been part in the disease disclosure 
conversation (Paper II). A child can tolerate discomfort if he or she is prepared 
for it, understands its real purpose and receives adequate support from 
understanding adults. Parents also need information, since their emotional 
stability is necessary for the child’s psychological well-being. In our study, we 
found that inadequate information provided to the parent was an important 
predictor for non-adherence to the prescribed medical regimen. Clearly, 
communication between the health care providers and the patient is an important 
factor for adherence [50]. When patients understand their physicians they tend to 
follow their treatment regimen and modify their behavior to a larger degree [75]. 
Furthermore, in a study made by Safran et al., trust was found to be a key 
element in the patient–physician relationship and older patients who trust their 
physician were among those who complied best with the medical regimen [58]. 
We have previously reported a lack of trust in the child’s physicians and the 
health care professionals in our study group (Paper I). We can now show that 
adherence to medication while at home was more commonly reported in parents 
who trusted the physicians and the health care professionals (Paper II). 
Furthermore, Perez-Carceles et al., conducted a cross-sectional survey at an 
urban Spanish university hospital of 300 patients admitted to the emergency 
department during a period of three months [76]. They found a significant 
relation between perceived information to the patient and his or her satisfaction 
with the care [76]. These data are supported by our previous findings that 
parental satisfaction depends upon the quality of communication with health 
care professionals (Paper I).  
Taking time to understand the child and family builds trust, leading to increased 
reporting of the actual reason for the visit and influences treatment adherence 
and outcome, adaptation to disease, and bereavement [72]. Nonetheless, several 
studies within the field of psychology and psychiatry have observed that psycho-
education and the provision of information are most effective when aligned with 
behavioral and problem-solving strategies to enhance and promote adherence 
[28,77,78,79]. Adherence to oral chemotherapy in childhood malignancies is a 
complex, multidimensional behavior that requires understanding on the part of 
the parent and child and also requires that they correctly carry out complex 
instructions from the health care provider about a variety of medications. These 
instructions take into account factors including the time of the day when the 
medication is to be administered, whether the medication must be administered 
by restricting intake of certain products such as dairy products or must be taken 
on an empty stomach. All these factors may require frequent dose adjustments in 
response to blood counts, infections, clinical course, or changes in weight or 
body surface area. Therefore, adherence involves not only a willingness to 
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follow the regimen over a prolonged, defined period, but also the cognitive 
competence and psychomotor skills to carry out the process. Hence, the role of 
the parents in supporting, guding and aiding their child is crucial. 
7.4!PAPER!IV!
Among the 304 children diagnosed with cancer at Children’s Cancer Hospital in 
Egypt, 281 children were followed up after five years and we found that 58 
percent (n=176) had survived five years after treatment diagnosis with an 
additional 10 percent lost to follow-up. Thus, the survival rates in our study 
group have increased considerably in comparison with the rates estimated 
(between 20% to 30%) by the NCI Egypt and WHO in the past [10,20,80] and 
before the new hospital started running. These survival rates are not yet 
comparable to the estimated rates in Western countries; nevertheless, they only 
reflect our study group and not the general overall rates of the entire hospital.  
Various obstacles are addressed in the litterature accounting for the high 
mortality rates in this part of the world. Among others, inadequate access to 
medical care, lack of education and knowledge in seeking health care, long 
distance transportation and limited access and absence of effective 
chemotherapy drugs [10]. These challenges have to a large degree been 
overcome at the Children’s Cancer Hospital in Cairo in various ways. Major 
awareness campaigns have been broadcast all over the country regarding 
prevention, detection, dietary awareness and seeking health care as well as 
defeating the stigma attached to cancer and bringing hope to people by 
informing them about the effective treatment that the hospital offers by engaging 
the treated and cured children in the ads. 
Probable explanations of the relatively increased survival rates at the hospital 
could be the overall cancer treatment provided (chemotherapy, radiation, 
surgery and physiotherapy) that corresponds to the US protocols with 
modifications tailored for the children in Egypt as well as the a multi-speciality 
ward at the hospital that offers a wide range of specialists. This service has 
helped in controlling and avoiding health complications for the child as the 
specialists have access to the child’s medical records and can prescribe 
medication that does not have a synergistic effect on the child’s cancer 
treatment. This service has certainly saved the parents’ money and time and 
provided convenience and encouraged health care seeking as well as brought 
about effective health care provided to the child.  
In addition, one of the major prior concerns regarding survival in childhood 
cancer in Egypt has been the long distance between the child’s home and the 
hospital and the lack of transportation to hospitals among rural inhabitants 
[10,20]. Interestingly, we found no difference in survival rates during the five-
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year follow-up between urban (68%, 61/90) and rural (63%, 113/180) residents. 
This could to a certain degree be explained by the offered transportation 
allowance that the parents are offered to/from the hospital as well as the housing 
alternatives offered during treatment if the child lives too far away from the 
hospital or if he or she is too tired to travel back home. Furthermore, the hospital 
has established a welfare foundation for financial assistance and for other types 
of compensations such as loss of or decreased salary due to reduced working 
hours/days when the parent is at hospital for treatment of the child.  
We found an association between information and the way it is provided with 
trust and adherence to medication, yet none of these predictors were related to 
survival in our study group except for mother’s educational level. We also 
investigated other psychosocial and demographic factors along with other 
factors related to the child (gender, age, BMI) to find out if any of those 
predictors are related to survival and none of them turned out to be predictors. 
Therefore, our hypothesis was refuted as no statistically significant differences 
were found between the group that survived and the group that died in relation 
to psychosocial predictors addressed above. 
The Children’s Cancer Hospital may not be representative of the quality of care 
that is found in other hospitals in Egypt or the rest of the region, although it is 
free of charge like any governmental hospital. Hence, the overall mortality rates 
in Egypt will probably not decrease more since the hospital only accommodates 
one-fourth of all patients in the entire country. 
!
! 43!
year follow-up between urban (68%, 61/90) and rural (63%, 113/180) residents.
This could to a certain degree be explained by the offered transportation
allowance that the parents are offered to/from the hospital as well as the housing 
alternatives offered during treatment if the child lives too far away from the 
hospital or if he or she is too tired to travel back home. Furthermore, the hospital
has established a welfare foundation for financial assistance and for other types 
of compensations such as loss of or decreased salary due to reduced working
hours/days when the parent is at hospital for treatment of the child. 
We found an association between information and the way it is provided with
trust and adherence to medication, yet none of these predictors were related to 
survival in our study group except for mother’s educational level. We also
investigated other psychosocial and demographic factors along with other
factors related to the child (gender, age, BMI) to find out if any of those
predictors are related to survival and none of them turned out to be predictors. 
Therefore, our hypothesis was refuted as no statistically significant differences
were found between the group that survived and the group that died in relation 
to psychosocial predictors addressed above.
The Children’s Cancer Hospital may not be representative of the quality of care
that is found in other hospitals in Egypt or the rest of the region, although it is
free of charge like any governmental hospital. Hence, the overall mortality rates
in Egypt will probably not decrease more since the hospital only accommodates
one-fourth of all patients in the entire country.
! 44!
8 !CONCLUS ION!
This thesis provides psycho-oncological knowledge about children diagnosed 
with cancer in Egypt. The main aim of the research on which this thesis is based 
is to explore predictors of the high mortality rates predicted among these 
children in Egypt.  
We found that: 
• Parents reported a higher degree of trust in the health care provided and in 
their child’s physician if they were met with care. Also, having received 
information concerning the diagnosis and treatment was associated with 
higher trust in the health care provided and in the physicians. The 
majority of the parents did not, however, receive information about the 
disease and treatment. 
 
• Disease disclosure is common among our study group where 72 percent 
of the parents did receive their child’s diagnosis from the physician. Yet, 
only 39 percent of the children were present during the conversation. 
Nevertheless, the use of medical terms and possible colloquial equivalents 
in disclosing the information to the parent is controversial, as the terms 
used do not clearly convey the nature of the disease. 
 
• Non-adherence to prescribed medication while at home is common among 
our study group (68%) and two main predictors reported by the parents 
were child’s resistance (90%) and inadequate information provided to the 
parents (85%). The adherent group reported more knowledge about their 
child’s disease in comparison to the non-adherent group (adherent 48/58, 
83%, and non-adherent 82/123, 67%, P=0.02). Among the non-adherent 
group only 8/123 reported trust in their child’s physician and health care 
professionals. 
 
• The five-year survival rates among our study group are compared with the 
currect statitstics (58%) with an additional 10 percent lost to follow-up; 
nevertheless, we could not relate the surviving or non-surviving groups to 
any of the psychosocial predictors addressed in this thesis. 
In this thesis I argue that the patient–physician relationship is an essential factor 
affecting the nature of the care provided and ultimately the evaluation of the 
quality of care. This relationship is influenced by a number of elements, some of 
which are addressed in this thesis. It is apparent from our data that parents to 
cancer-sick children do not differ markedly in thoughts, feelings and actions 
! 44!
8 !CONCLUS ION!
This thesis provides psycho-oncological knowledge about children diagnosed 
with cancer in Egypt. The main aim of the research on which this thesis is based 
is to explore predictors of the high mortality rates predicted among these 
children in Egypt.  
We found that: 
• Parents reported a higher degree of trust in the health care provided and in 
their child’s physician if they were met with care. Also, having received 
information concerning the diagnosis and treatment was associated with 
higher trust in the health care provided and in the physicians. The 
majority of the parents did not, however, receive information about the 
disease and treatment. 
 
• Disease disclosure is common among our study group where 72 percent 
of the parents did receive their child’s diagnosis from the physician. Yet, 
only 39 percent of the children were present during the conversation. 
Nevertheless, the use of medical terms and possible colloquial equivalents 
in disclosing the information to the parent is controversial, as the terms 
used do not clearly convey the nature of the disease. 
 
• Non-adherence to prescribed medication while at home is common among 
our study group (68%) and two main predictors reported by the parents 
were child’s resistance (90%) and inadequate information provided to the 
parents (85%). The adherent group reported more knowledge about their 
child’s disease in comparison to the non-adherent group (adherent 48/58, 
83%, and non-adherent 82/123, 67%, P=0.02). Among the non-adherent 
group only 8/123 reported trust in their child’s physician and health care 
professionals. 
 
• The five-year survival rates among our study group are compared with the 
currect statitstics (58%) with an additional 10 percent lost to follow-up; 
nevertheless, we could not relate the surviving or non-surviving groups to 
any of the psychosocial predictors addressed in this thesis. 
In this thesis I argue that the patient–physician relationship is an essential factor 
affecting the nature of the care provided and ultimately the evaluation of the 
quality of care. This relationship is influenced by a number of elements, some of 
which are addressed in this thesis. It is apparent from our data that parents to 
cancer-sick children do not differ markedly in thoughts, feelings and actions 
!! 45!
regardless of cultural, religious, or technology advancement. Nevertheless, we 
find in our study group that the main concerns about the patient–physician 
relationship remain. This relationship entails a range of mutual responsibilities 
that include respect, open and honest communication, and trust. It also entails 
acknowledging and encouraging the parent’s desired involvement in the care, 
the process of disease disclosure, and the adherence to prescribed medication 
regimen while at home as well as the obstacles the parents encounter in that. 
Despite the fact that we did not find an association between psychosocial 
elements and mortality, we could, however, report numerous psychological and 
social needs that the parents have addressed. 
Apparently, the financial incentives the hospital is offering children of low-
income families play an important role in encouraging as well as enhancing 
adherence to treatment at the hospital at least as concerns the parents in our 
study group who were compliant with the treatment schedule on a large scale so 
that lateness to treatment was not an issue. 
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9 ! FUTURE !PERSPECT IVES !
The findings presented in this thesis could be seen as just one step, but a 
necessary step, towards providing better psychosocial and psychological health 
among the children diagnosed with cancer and among the parents of these 
children in Egypt.  
The Children’s Cancer Hospital (CCHE) is unique and has brought about a 
noticeable improvement in the level of cancer health care in Egypt. 
Nevertheless, in reality, CCHE does not provide for the majority of the children 
in Egypt as it annually accommodates only one-fourth of all diagnosed children. 
Despite the fact that the situation for the children and their parents at CCHE is 
different from that at all governmental hospitals, the needs and concerns are 
similar yet vary in degrees as observed in my master’s thesis conducted at the 
three major governmental hospitals in Egypt.  
My thesis indicates that findings in the Western countries are relevant also for 
Egypt. The Western literature has emphasised and repeatedly acknowledged the 
integral part of psychosocial issues in medicine especially in pediatric oncology, 
satisfactory patient–physician communication is crucial for children diagnosed 
with cancer and their parents. Providing information about disease, treatment 
and treatment progress is important for the families. Nevertheless, the way 
information is provided, in a thoughtful and caring way, is equally crucial in 
creating a mutual relationship that creates confidence towards the health care 
team in general and the physicians specifically. This is the core of the 
relationship that does not seem to be established yet in Egypt.  
As my thesis indicate, the parents are indeed their own child’s social reference 
and their attributes, approach and reactions influence the child in many ways, 
not the least in their thoughts, feelings and behaviors. Therefore, the focus 
should be on providing a holistic approach where the child, the parents, the 
health care professionals, and the treating physician are all involved. Though a 
propotional increase in survival rates has been seen in Egypt at CCHE, 
improvements in psychosocial matters have not followed the same progression 
that would entail better quality of life for the children and parents and a better 
future to look forward to. Apparently, from our data we can see that parenthood 
and childhood concerns and needs are similar across the nations with, however, 
clear cultural and religious modifications. The Western psychosocial research, 
interventions and programs are applicable in the Egyptian setting if the health 
care providers want to increase the parents’ degree of trust in the health care 
system and create a healthy patient–physician relationship. Therefore, it would 
probably be fruitful, from this perspective to transfer knowledge from Western 
psychosocial programs and support. In order to optimize the present 
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psychosocial services to the child and parents, it is also crucial to educate the 
health care professionals in all aspects of psychosocial care; establishing a 
proper communication channel and meeting the practical and emotional needs 
and concerns of the sick child and his or her family. It all falls under the patient–
physician relationship and all that it entails. 
The material we have obtained can be used to answer other questions regarding 
the various clinical procedures the child goes through before and after diagnosis 
as well as other psychosocial data. Nevertheless, additional studies are 
suggested and recommended, studies such as investigating the possible 
predictors for non-adherence from the child’s perspective and looking at the 
direct financial and health consequences of that. Also, future studies may 
provide a perspective of the child on how he or she comprehends what the 
physicians say and how he or she understands the diagnosis and the disease 
itself as well as how it reflects on his or her relationship with the parent and 
peers. Future intervention studies may address the needs and concerns of the 
child and his or her perception of the disease and hospital stay as well as the 
transitional period of being at the hospital and returning to home and school. In 
addition, there is a need to investegate the consequences and benefits of 
communicating with the child about the disease, treatment, disease progression 
and death in a society like Egypt.  
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10 ! SUMMARY ! IN !SWEDISH !– !
SAMMANFATTNING!PÅ !SVENSKA !
Bakgrund: Enligt officiell statistik dör varje år över 70 procent av de barn i 
Egypten som diagnotiserats med cancer. Motsvarande siffra i Sverige är cirka 20 
procent. En tidigare kvalitativ studie har visat att föräldrars brist på tillit till 
sjukvården leder till minskad följsamhet till ordinerad behandling, vilket skulle 
tänkas kunna påverka dosintensitet och leda till ökad mortalitet. Vi bestämde oss 
för att gå vidare med en studie för att undersöka om psykosociala faktorer har 
betydelse för den låga överlevnaden. 
 
Syfte: Huvudsyftet med studien var att ta fram psykoonkologisk kunskap, för att 
kunna skapa en bättre cancervård i Egypten. Detta gjordes genom att undersöka 
dels samvariationen mellan psykosociala faktorer (såsom tillit och följsamhet till 
behandling) och överlevnad, dels föräldrarnas inställning till sjukvården och 
sjukvårdspersonalen. Huvudhypotesen för studien var att föräldrars brist på tillit 
till sjukvården vid barnets första cytostatikabehandling har en tendens att 
minska dosintensiteten för de efterföljande behandlingscyklerna, och därmed 
barnets möjlighet att överleva. 
 
Metod: Vi utvecklade och testade två studiespecifika enkäter som riktar sig till 
föräldrar med cancersjuka barn vid Egyptens (och Afrikas) största 
barncancersjukhus i Kairo (Children’s Cancer Hospital in Egypt, CCHE) och 
därefter genomfördes en pilotstudie. Från februari till september 2008 samlades 
data in från 304 föräldrar till cancersjuka barn intagna på CCHE för sin första 
cytostatikabehandling. Den första enkäten delades ut före den första 
behandlingscykeln och den andra efter den tredje behandlingscykeln. Eftersom 
många av föräldrarna inte var läskunniga erbjöds stöd och hjälp på sjukhuset vid 
ifyllandet av enkäterna.  
 
Resultat: Av 313 tillfrågade föräldrar besvarade 304 (97 %) den första enkäten 
och 281 (92 %) den andra. Studien visade en samvariation mellan 
sjukvårdspersonalens bemötande och föräldrarnas tillit. Föräldrarnas tillit till 
sjukvårdspersonalen efter barnets tredje behandlingscykel samvarierade med 
följande faktorer vid tiden för den första behandlingen: de fick information om 
sjukdomen (relativ risk (RR) 13,2; 95 % KI 7,8–22,3) och behandlingen (RR 
17,2; 95 % KI 9,5–31,4), de fick möjlighet att kommunicera med barnets läkare 
(RR 21,3; 95 % KI 11,7–38,8), de var nöjda med det sätt som barnets läkare 
kommunicerade på (RR 30,6; 95 % KI 14,4–64,9), de fick sina emotionella 
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SAMMANFATTNING!PÅ !SVENSKA !
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behov tillfredsställda (RR 22,2; 95 % KI 11,8–41,9), och barnets läkare visade 
omtanke vid bemötandet (RR 32,0; 95 % KI 15,2–67,7). Den starkaste 
prediktorn för tillit vid barnets tredje behandlingscykel, efter multivariabel 
modellering, var att läkaren visade omtanke om föräldrarna.  
Studien visade även att mer än två tredjedelar av barnen fick behandlings-
rekommendationer vid hemgång och att en tredjedel av föräldrarna till barnen 
rapporterade att deras barn inte följde dessa (123/181). Nästan alla föräldrar 
upplevde att rekommendationerna var relevanta (120/123, 98 %) men tre av fyra 
(76 %) hade svårt att följa dem. Barnens motstånd mot behandlingen (117/123, 
95 %) och otillräcklig information (105/123, 85 %) var de två 
huvudprediktorerna för bristande följsamhet till behandlings-
rekommendationerna. Nästan alla föräldrar rapporterade brist på tillit till 
behandlingen (116/121, 96 %), men hade ändå för avsikt att fullfölja 
behandlingen av rädsla för att barnet annars skulle dö (99/123, 81 %). Av de 
föräldrar vars barn följde behandlings-rekommendationerna hemma, 
rapporterade 12 av 58 (20 %) tillit till läkare och sjukvårdspersonal.  
Vi fann även att en stor andel av föräldrarna (72 %) fick besked om 
cancerdiagnosen från barnets läkare. Av dessa hade 39 procent barnen med sig 
under samtalet. Åldern bland barnen som var med under samtalet var fördelad i 
grupperna 0–4 år (45 %), 5–8 år (20 %), 9–15 år (30 %) och 16–18 år (5 %). 
Majoriteten av läkarna talade om sjukdomen som en “tumör” (n=292), medan 
“svår sjukdom” var den näst vanligaste benämningen (n=161). “Malign 
sjukdom” (n=31) och “cancer” (saratan på arabiska) (n=18) användes däremot 
mer sällan.  
Avslutningsvis kunde vi se att överlevnaden i vår studiepopulation fem år efter 
datainsamlingen efter första behandlingen var 58 procent (n=176) med ett 10-
procentigt bortfall (”lost to follow-up”) där troligen några barn överlevt. 
Majoriteten av de avlidna barnen hade leukemi (n=22) men även andra 
cancerformer som lymfom (n=10), hjärntumör (n=7), neuroblastom (n=5), 
sarkom (n=5) och “andra typer av tumörer” (n=8) förekom. Vi kunde inte se 
någon korrelation mellan barn som överlevt/inte överlevt gällande olika 
psykosociala faktorer såsom att komma i tid till behandlingen, information given 
vid diagnos, föräldrarnas tillit till sjukvården, läkarna, eller behandlingen. 
Lärdom: Vi kunde inte bekräfta vår huvudhypotes att föräldrarnas grad av tillit 
påverkar dosintensiteten och därmed också barnens möjlighet till överlevnad. 
Den överlevnad som vi uppmätte (58 %) är högre än de överlevnadssiffror som 
tidigare angivits i officiell statistik och innan verksamheten vid CCHE började. 
Dock bör nämnas att till vår noterade överlevnad skall adderas en osäkerhet på 
10 procent då 30 barn inte har kunnat följas upp på grund av att det saknas data 
för dessa. Däremot tycks följsamheten till behandlingen hemma bero på graden 
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av föräldrarnas tillit till läkare och sjukvårdspersonal, men ingen samvariation 
finns mellan tillit eller följsamhet och överlevnad. Vi fann en stark samvariation 
mellan huruvida 1) information till föräldrar gavs eller inte samt 2) på vilket sätt 
information gavs före barnets första behandlingscykel och graden av tillit före 
barnets tredje behandlingscykel. 
Brukbarhet: Våra data tyder på att föräldrar till cancersjuka barn i stor 
utsträckning har samma tankar, känslor och behov oberoende av var i världen de 
befinner sig och oberoende av tradition, kultur, utbildningsgrad och teknologisk 
standard. Att utbilda sjukvårdspersonalen i kommunikation och bemötande kan 
ses som ett första led i att förbättra tilliten bland föräldrar med cancersjuka barn 
och öka följsamheten till behandlingen. Den psykoonkologiska kunskap vi har 
tagit fram skulle kunna vara till hjälp för sjukvårdspersonal med ambitionen att 
skapa en bättre vård av cancersjuka barn och ett bättre bemötande av deras 
föräldrar i Egypten eller i andra länder med arabiska befolkningar.  
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